secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001104659-23-072250
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio shareholders approve doubling authorized common stock to 70M shares at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amendment to increase authorized common shares from 35M to 70M.
- Charter amendment received 5,699,648 votes for, 633,577 against, and 9,357 abstentions.
- All five director nominees elected: Michael Hoffman, Maria Maccecchini, Claudine Bruck, Reid McCarthy, Mark White.
- A total of 6,342,582 shares represented at the meeting out of 9,005,131 eligible.
- Broker non-votes of 2,307,303 recorded for each director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/0001104659-23-072250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465923072250/tm2318997d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer